Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Mise à jour : Il y a 4 ans
Référence : NCT00338351

Femme et Homme

  • | Pays :
  • Chile
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Three dose primary vaccination study of reactogenicity and immunogenicity in healthy infants between 6-12 weeks of age at the time of the first vaccination against Streptococcus pneumoniae.


Critère d'inclusion

  • Hepatitis A

Liens